Graphene Neuroprobe Chips to Treat Severe Depression
Graphene Neuroprobe Chips to Treat Severe Depression
Graphene Neuroprobe Chips for Treating Depression
Tags: National Yang Ming Chiao Tung University, Taiwan, Healthcare & Lifesciences
NYCU’s research team, in collaboration with an international medical company, has developed graphene neuroprobe chips for deep brain electrical stimulation to treat depression. These chips are implanted in the brain's nucleus accumbens, targeting treatment-resistant depression by promoting neurotrophic factor production and improving brain function. The technology offers a more stable, long-term alternative to non-invasive treatments, reducing depressive symptoms in animal models. Applications include treating patients with severe depression who are unresponsive to conventional therapies. This research enhances our understanding of depression treatment mechanisms and supports future clinical applications.
IP Type or Form Factor: Design; Material; Platform
TRL: 4 - minimum viable product built in lab
Industry or Tech Area: Medical Devices; Mental Health
